{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:49:00Z","timestamp":1792064940576,"version":"4.4.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"DOI":"10.1007\/s13402-026-01254-x","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:34:20Z","timestamp":1784554460000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mitochondrial stress-induced cuproptosis: a metabolic bridge to reprogramming the GBM immune microenvironment"],"prefix":"10.1007","volume":"49","author":[{"given":"Wenyang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqing","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanrong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leina","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2921-8866","authenticated-orcid":false,"given":"Hai","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"1254_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"H. Sung, J. Ferlay, R.L. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal et al., Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. Wiley Online Libr. 71, 209\u2013249 (2021)","journal-title":"CA Cancer J. Clin. Wiley Online Libr."},{"key":"1254_CR2","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12951-025-03247-8","volume":"23","author":"J Liu","year":"2025","unstructured":"J. Liu, T. Wang, J. Dong, Y. Lu, The blood\u2013brain barriers: novel nanocarriers for central nervous system diseases. J. Nanobiotechnol. [Internet]. 23, 146 (2025). https:\/\/doi.org\/10.1186\/s12951-025-03247-8","journal-title":"J. Nanobiotechnol. [Internet]"},{"key":"1254_CR3","doi-asserted-by":"publisher","first-page":"e24729","DOI":"10.1016\/j.heliyon.2024.e24729","volume":"10","author":"H Wang","year":"2024","unstructured":"H. Wang, J. Yang, X. Li, H. Zhao, Current state of immune checkpoints therapy for glioblastoma. Heliyon [Internet]. 10, e24729 (2024). https:\/\/doi.org\/10.1016\/j.heliyon.2024.e24729","journal-title":"Heliyon [Internet]"},{"key":"1254_CR4","doi-asserted-by":"publisher","first-page":"101412","DOI":"10.1016\/j.drup.2026.101412","volume":"87","author":"J-Y Sung","year":"2026","unstructured":"J.-Y. Sung, K. Hwang, Breaking immune isolation in glioblastoma. Drug Resist. Updat [Internet]. 87, 101412 (2026). https:\/\/doi.org\/10.1016\/j.drup.2026.101412","journal-title":"Drug Resist. Updat [Internet]"},{"key":"1254_CR5","doi-asserted-by":"crossref","unstructured":"Y. Liu, F. Zhou, H. Ali, J.D. Lathia, P. Chen, Immunotherapy for glioblastoma: current state, challenges, and future perspectives. Cell Mol Immunol. 1\u201322 (2024)","DOI":"10.1038\/s41423-024-01226-x"},{"key":"1254_CR6","doi-asserted-by":"publisher","unstructured":"C. Jackson, C. Cherry, S. Bom, A.G. Dykema, R. Wang, E. Thompson et al., Distinct myeloid-derived suppressor cell populations in human glioblastoma. Science (80-) [Internet]. American Association for the Advancement of Science. 387:eabm5214. (2026)https:\/\/doi.org\/10.1126\/science.abm5214","DOI":"10.1126\/science.abm5214"},{"key":"1254_CR7","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41698-025-00920-x","volume":"9","author":"W Zhao","year":"2025","unstructured":"W. Zhao, Z. Zhang, M. Xie, F. Ding, X. Zheng, S. Sun et al., Exploring tumor-associated macrophages in glioblastoma: from diversity to therapy. npj Precis Oncol. [Internet]. 9, 126 (2025). https:\/\/doi.org\/10.1038\/s41698-025-00920-x","journal-title":"npj Precis Oncol. [Internet]"},{"key":"1254_CR8","doi-asserted-by":"publisher","unstructured":"D.F. Quail, J.A. Joyce, The microenvironmental landscape of brain tumors. Cancer. Cell. 326\u2013341 (2017). https:\/\/doi.org\/10.1016\/j.ccell.2017.02.009","DOI":"10.1016\/j.ccell.2017.02.009"},{"key":"1254_CR9","doi-asserted-by":"crossref","unstructured":"S. Che, Z. Yan, Y. Feng, H. Zhao, Unveiling the intratumoral microbiota within cancer landscapes. Iscience (2024)","DOI":"10.1016\/j.isci.2024.109893"},{"key":"1254_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nri.2016.107","volume":"17","author":"L Galluzzi","year":"2017","unstructured":"L. Galluzzi, A. Buqu\u00e9, O. Kepp, L. Zitvogel, G. Kroemer, Immunogenic cell death in cancer and infectious disease. Nat. Rev. Immunol. Nat. Publishing Group. UK Lond. 17, 97\u2013111 (2017)","journal-title":"Nat. Rev. Immunol. Nat. Publishing Group. UK Lond."},{"key":"1254_CR11","doi-asserted-by":"publisher","unstructured":"D. Hanahan, Hallmarks of cancer: new dimensions. Cancer. Discov. 31\u201346 (2022) https:\/\/doi.org\/10.1158\/2159-8290.CD-21-1059","DOI":"10.1158\/2159-8290.CD-21-1059"},{"key":"1254_CR12","first-page":"e724","volume":"5","author":"Y Yang","year":"2024","unstructured":"Y. Yang, J. Wu, L. Wang, G. Ji, Y. Dang, Copper homeostasis and cuproptosis in health and disease. MedComm Wiley Online Libr. 5, e724 (2024)","journal-title":"MedComm Wiley Online Libr."},{"key":"1254_CR13","doi-asserted-by":"publisher","unstructured":"Z. Yang, R. Feng, H. Zhao, Cuproptosis and Cu: a new paradigm in cellular death and their role in non-cancerous diseases. Apoptosis. 1\u201331 (2024). https:\/\/doi.org\/10.1007\/s10495-024-01993-y","DOI":"10.1007\/s10495-024-01993-y"},{"key":"1254_CR14","doi-asserted-by":"publisher","unstructured":"Y. Feng, Z. Yang, J. Wang, H. Zhao, Cuproptosis: unveiling a new frontier in cancer biology and therapeutics. Cell. Commun. Signal. 22 (2024). https:\/\/doi.org\/10.1186\/s12964-024-01625-7","DOI":"10.1186\/s12964-024-01625-7"},{"key":"1254_CR15","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"P. Tsvetkov, S. Coy, B. Petrova, M. Dreishpoon, A. Verma, M. Abdusamad et al., Copper induces cell death by targeting lipoylated TCA cycle proteins. Sci. (80-). 375, 1254\u20131261 (2022). https:\/\/doi.org\/10.1126\/science.abf0529","journal-title":"Sci. (80-)"},{"key":"1254_CR16","first-page":"752","volume":"57","author":"M Ma","year":"2024","unstructured":"M. Ma, W. Jiang, R. Zhou, DAMPs and DAMP-sensing receptors in inflammation and diseases. Immun. Elsevier. 57, 752\u2013771 (2024)","journal-title":"Immun. Elsevier"},{"key":"1254_CR17","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41577-019-0215-7","volume":"20","author":"T Gong","year":"2020","unstructured":"T. Gong, L. Liu, W. Jiang, R. Zhou, DAMP-sensing receptors in sterile inflammation and inflammatory diseases. Nat. Rev. Immunol. Nat. Publishing Group. UK Lond. 20, 95\u2013112 (2020)","journal-title":"Nat. Rev. Immunol. Nat. Publishing Group. UK Lond."},{"key":"1254_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1346585","author":"H Wang","year":"2024","unstructured":"H. Wang, Y. Liu, S. Che, X. Li, D. Tang, S. Lv et al., Deciphering the link: ferroptosis and its role in glioma. Front. Immunol. (2024). https:\/\/doi.org\/10.3389\/fimmu.2024.1346585","journal-title":"Front. Immunol."},{"key":"1254_CR19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1741-7007-12-34","volume":"12","author":"NS Chandel","year":"2014","unstructured":"N.S. Chandel, Mitochondria as signaling organelles. BMC Biol. Springer. 12, 34 (2014)","journal-title":"BMC Biol. Springer"},{"key":"1254_CR20","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1002\/cac2.70067","volume":"45","author":"Y Yan","year":"2025","unstructured":"Y. Yan, X. Tan, B. Song, M. Yi, Q. Chu, K. Wu, Breaking barriers: The cGAS-STING pathway as a novel frontier in cancer immunotherapy. Cancer Commun. Wiley Online Libr. 45, 1513\u20131546 (2025)","journal-title":"Cancer Commun. Wiley Online Libr."},{"key":"1254_CR21","doi-asserted-by":"crossref","unstructured":"H. Ren, Y. Tang, D. Zhang, The emerging role of protein L-lactylation in metabolic regulation and cell signalling. Nat. Metab. 1\u201318 (2025)","DOI":"10.1038\/s42255-025-01259-0"},{"key":"1254_CR22","doi-asserted-by":"publisher","unstructured":"K. Zhao, C. Wu, X. Li, M. Niu, D. Wu, X. Cui et al., From mechanism to therapy: the journey of CD24 in cancer. Front. Immunol. [Internet]. 15 (2024). https:\/\/doi.org\/10.3389\/fimmu.2024.1401528","DOI":"10.3389\/fimmu.2024.1401528"},{"key":"1254_CR23","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/s41579-025-01213-7","volume":"23","author":"JD Helmann","year":"2025","unstructured":"J.D. Helmann, Microbial metal physiology: ions to ecosystems. Nat. Rev. Microbiol. Nat. Publishing Group. UK Lond. 23, 805\u2013819 (2025)","journal-title":"Nat. Rev. Microbiol. Nat. Publishing Group. UK Lond."},{"key":"1254_CR24","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41568-021-00417-2","volume":"22","author":"EJ Ge","year":"2022","unstructured":"E.J. Ge, A.I. Bush, A. Casini, P.A. Cobine, J.R. Cross, G.M. DeNicola et al., Connecting copper and cancer: from transition metal signalling to metalloplasia. Nat. Rev. Cancer Nat. Publishing Group. UK Lond. 22, 102\u2013113 (2022)","journal-title":"Nat. Rev. Cancer Nat. Publishing Group. UK Lond."},{"key":"1254_CR25","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12943-022-01668-9","volume":"21","author":"X Qi","year":"2022","unstructured":"X. Qi, S.K. Jha, N.K. Jha, S. Dewanjee, A. Dey, R. Deka et al., Antioxidants in brain tumors: current therapeutic significance and future prospects. Mol. Cancer Springer. 21, 204 (2022)","journal-title":"Mol. Cancer Springer"},{"key":"1254_CR26","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/cac2.70005","volume":"45","author":"D Shan","year":"2025","unstructured":"D. Shan, J. Song, Y. Ren, Y. Zhang, Y. Ba, P. Luo et al., Copper in cancer: friend or foe? Metabolism, dysregulation, and therapeutic opportunities. Cancer Commun. Wiley Online Libr. 45, 577\u2013607 (2025)","journal-title":"Cancer Commun. Wiley Online Libr."},{"key":"1254_CR27","first-page":"2305095","volume":"37","author":"Y Cheng","year":"2025","unstructured":"Y. Cheng, Z. Qu, Q. Jiang, T. Xu, H. Zheng, P. Ye et al., Functional materials for subcellular targeting strategies in cancer therapy: progress and prospects. Adv. Mater. Wiley Online Libr. 37, 2305095 (2025)","journal-title":"Adv. Mater. Wiley Online Libr."},{"key":"1254_CR28","doi-asserted-by":"publisher","first-page":"117725","DOI":"10.1016\/j.ecoenv.2025.117725","volume":"290","author":"W Ling","year":"2025","unstructured":"W. Ling, S. Li, Y. Zhu, X. Wang, D. Jiang, B. Kang, Inducers of autophagy and cell death: focus on copper metabolism. Ecotoxicol. Environ. Saf. Elsevier. 290, 117725 (2025)","journal-title":"Ecotoxicol. Environ. Saf. Elsevier"},{"key":"1254_CR29","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41420-025-02390-3","volume":"11","author":"L Lu","year":"2025","unstructured":"L. Lu, Y. Zhang, Y. Yang, M. Jin, A. Ma, X. Wang et al., Lipid metabolism: the potential therapeutic targets in glioblastoma. Cell. Death Discov Nat. Publishing Group. UK Lond. 11, 107 (2025)","journal-title":"Cell. Death Discov Nat. Publishing Group. UK Lond."},{"key":"1254_CR30","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1080\/15548627.2023.2165323","volume":"19","author":"Q Xue","year":"2023","unstructured":"Q. Xue, D. Yan, X. Chen, X. Li, R. Kang, D.J. Klionsky et al., Copper-dependent autophagic degradation of GPX4 drives ferroptosis. Autophagy [Internet]. 19, 1982\u20131996 (2023). https:\/\/doi.org\/10.1080\/15548627.2023.2165323","journal-title":"Autophagy [Internet]"},{"key":"1254_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4684-3270-1_1","volume":"74","author":"H Matsubara","year":"1976","unstructured":"H. Matsubara, K. Wada, R. Masaki, Structure and function of chloroplast-type ferredoxins. Adv. Exp. Med. Biol. United States. 74, 1\u201315 (1976). https:\/\/doi.org\/10.1007\/978-1-4684-3270-1_1","journal-title":"Adv. Exp. Med. Biol. United States"},{"key":"1254_CR32","doi-asserted-by":"publisher","first-page":"103302","DOI":"10.1016\/j.redox.2024.103302","volume":"75","author":"B Sun","year":"2024","unstructured":"B. Sun, P. Ding, Y. Song, J. Zhou, X. Chen, C. Peng et al., FDX1 downregulation activates mitophagy and the PI3K\/AKT signaling pathway to promote hepatocellular carcinoma progression by inducing ROS production. Redox Biol. Neth. 75, 103302 (2024). https:\/\/doi.org\/10.1016\/j.redox.2024.103302","journal-title":"Redox Biol. Neth."},{"key":"1254_CR33","doi-asserted-by":"publisher","first-page":"e18187","DOI":"10.1111\/jcmm.18187","volume":"28","author":"Z Chen","year":"2024","unstructured":"Z. Chen, Y. Zhu, S. Chen, Z. Li, G. Fu, Y. Wang, Immune patterns of cuproptosis in ischemic heart failure: A transcriptome analysis. J. Cell. Mol. Med. Engl. 28, e18187 (2024). https:\/\/doi.org\/10.1111\/jcmm.18187","journal-title":"J. Cell. Mol. Med. Engl."},{"key":"1254_CR34","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/s41418-022-01094-w","volume":"30","author":"E Vringer","year":"2023","unstructured":"E. Vringer, S.W.G. Tait, Mitochondria and cell death-associated inflammation. Cell. Death Differ. Engl. 30, 304\u2013312 (2023). https:\/\/doi.org\/10.1038\/s41418-022-01094-w","journal-title":"Cell. Death Differ. Engl."},{"key":"1254_CR35","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41580-019-0173-8","volume":"21","author":"FJ Bock","year":"2020","unstructured":"F.J. Bock, S.W.G. Tait, Mitochondria as multifaceted regulators of cell death. Nat. Rev. Mol. Cell. Biol. Engl. 21, 85\u2013100 (2020). https:\/\/doi.org\/10.1038\/s41580-019-0173-8","journal-title":"Nat. Rev. Mol. Cell. Biol. Engl."},{"key":"1254_CR36","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1152\/physrev.00013.2006","volume":"87","author":"G Kroemer","year":"2007","unstructured":"G. Kroemer, L. Galluzzi, C. Brenner, Mitochondrial membrane permeabilization in cell death. Physiol. Rev. United States. 87, 99\u2013163 (2007). https:\/\/doi.org\/10.1152\/physrev.00013.2006","journal-title":"Physiol. Rev. United States"},{"key":"1254_CR37","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.tibs.2025.09.001","volume":"50","author":"L Hohorst","year":"2025","unstructured":"L. Hohorst, U. Ros, A.J. Garcia-Saez, Mitochondrial dynamics and pore formation in regulated cell death pathways. Trends Biochem. Sci. Engl. 50, 1001\u20131014 (2025). https:\/\/doi.org\/10.1016\/j.tibs.2025.09.001","journal-title":"Trends Biochem. Sci. Engl."},{"key":"1254_CR38","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/s41586-025-08590-2","volume":"639","author":"T Yamada","year":"2025","unstructured":"T. Yamada, A. Ikeda, D. Murata, H. Wang, C. Zhang, P. Khare et al., Dual regulation of mitochondrial fusion by Parkin-PINK1 and OMA1. Nature. England. 639, 776\u2013783 (2025). https:\/\/doi.org\/10.1038\/s41586-025-08590-2","journal-title":"England"},{"key":"1254_CR39","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/s12943-025-02506-4","volume":"24","author":"A Alishvandi","year":"2025","unstructured":"A. Alishvandi, C. Aram, F.F. Shahrivar, P. Kesharwani, A. Sahebkar, Pyroptosis in cancer therapy: a double-edged sword for immune activation and tumor progression. Mol. Cancer Engl. 24, 297 (2025). https:\/\/doi.org\/10.1186\/s12943-025-02506-4","journal-title":"Mol. Cancer Engl."},{"key":"1254_CR40","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.apsb.2021.05.011","volume":"12","author":"PK Oduro","year":"2022","unstructured":"P.K. Oduro, X. Zheng, J. Wei, Y. Yang, Y. Wang, H. Zhang et al., The cGAS-STING signaling in cardiovascular and metabolic diseases: Future novel target option for pharmacotherapy. Acta Pharm. Sin B Neth. 12, 50\u201375 (2022). https:\/\/doi.org\/10.1016\/j.apsb.2021.05.011","journal-title":"Acta Pharm. Sin B Neth."},{"key":"1254_CR41","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s41577-021-00524-z","volume":"21","author":"A Decout","year":"2021","unstructured":"A. Decout, J.D. Katz, S. Venkatraman, A. Ablasser, The cGAS-STING pathway as a therapeutic target in inflammatory diseases. Nat. Rev. Immunol. Engl. 21, 548\u2013569 (2021). https:\/\/doi.org\/10.1038\/s41577-021-00524-z","journal-title":"Nat. Rev. Immunol. Engl."},{"key":"1254_CR42","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","volume":"19","author":"KV Swanson","year":"2019","unstructured":"K.V. Swanson, M. Deng, J.P.-Y. Ting, The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat. Rev. Immunol. Engl. 19, 477\u2013489 (2019). https:\/\/doi.org\/10.1038\/s41577-019-0165-0","journal-title":"Nat. Rev. Immunol. Engl."},{"key":"1254_CR43","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s12640-025-00766-y","volume":"43","author":"V Tom","year":"2025","unstructured":"V. Tom, V. Dixit, S. Pujar, K. Sasidharan, A. K, D. C, Novel in silico Evidence of Bisphenol A as a Neuroinflammatory Modulator through the cGAS-STING-NLRP3 Pathway. Neurotox. Res. United States. 43, 47 (2025). https:\/\/doi.org\/10.1007\/s12640-025-00766-y","journal-title":"Neurotox. Res. United States"},{"key":"1254_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.ai.2024.02.003","volume":"162","author":"O Shinde","year":"2024","unstructured":"O. Shinde, P. Li, The molecular mechanism of dsDNA sensing through the cGAS-STING pathway. Adv. Immunol. United States. 162, 1\u201321 (2024). https:\/\/doi.org\/10.1016\/bs.ai.2024.02.003","journal-title":"Adv. Immunol. United States"},{"key":"1254_CR45","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1146\/annurev-biochem-061516-044813","volume":"86","author":"K Kato","year":"2017","unstructured":"K. Kato, H. Omura, R. Ishitani, O. Nureki, Cyclic GMP-AMP as an Endogenous Second Messenger in Innate Immune Signaling by Cytosolic DNA. Annu. Rev. Biochem. United States. 86, 541\u2013566 (2017). https:\/\/doi.org\/10.1146\/annurev-biochem-061516-044813","journal-title":"Annu. Rev. Biochem. United States"},{"key":"1254_CR46","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.tcb.2020.05.006","volume":"30","author":"C Zierhut","year":"2020","unstructured":"C. Zierhut, H. Funabiki, Regulation and Consequences of cGAS Activation by Self-DNA. Trends Cell. Biol. Engl. 30, 594\u2013605 (2020). https:\/\/doi.org\/10.1016\/j.tcb.2020.05.006","journal-title":"Trends Cell. Biol. Engl."},{"key":"1254_CR47","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1097\/CM9.0000000000003889","volume":"138","author":"X Liu","year":"2025","unstructured":"X. Liu, C. Ding, J. Lu, N. Zhang, cGAS-STING: From immunology and oncology view. Chin. Med. J. (Engl) China. 138, 3050\u20133068 (2025). https:\/\/doi.org\/10.1097\/CM9.0000000000003889","journal-title":"Chin. Med. J. (Engl) China"},{"key":"1254_CR48","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/s42255-021-00385-9","volume":"3","author":"H-G Sprenger","year":"2021","unstructured":"H.-G. Sprenger, T. MacVicar, A. Bahat, K.U. Fiedler, S. Hermans, D. Ehrentraut et al., Cellular pyrimidine imbalance triggers mitochondrial DNA-dependent innate immunity. Nat. Metab. Ger. 3, 636\u2013650 (2021). https:\/\/doi.org\/10.1038\/s42255-021-00385-9","journal-title":"Nat. Metab. Ger."},{"key":"1254_CR49","doi-asserted-by":"publisher","first-page":"115109","DOI":"10.1016\/j.celrep.2024.115109","volume":"44","author":"VR Hyde","year":"2025","unstructured":"V.R. Hyde, C. Zhou, J.R. Fernandez, K. Chatterjee, P. Ramakrishna, A. Lin et al., Anti-herpetic tau preserves neurons via the cGAS-STING-TBK1 pathway in Alzheimer\u2019s disease. Cell. Rep. United States. 44, 115109 (2025). https:\/\/doi.org\/10.1016\/j.celrep.2024.115109","journal-title":"Cell. Rep. United States"},{"key":"1254_CR50","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/imr.13272","volume":"321","author":"P Holicek","year":"2024","unstructured":"P. Holicek, E. Guilbaud, V. Klapp, I. Truxova, R. Spisek, L. Galluzzi et al., Type I interferon and cancer. Immunol. Rev. Engl. 321, 115\u2013127 (2024). https:\/\/doi.org\/10.1111\/imr.13272","journal-title":"Immunol. Rev. Engl."},{"key":"1254_CR51","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/bs.ai.2019.11.005","volume":"145","author":"S Liang","year":"2020","unstructured":"S. Liang, L. Ji, L. Kang, X. Hu, Metabolic regulation of innate immunity. Adv. Immunol. United States. 145, 129\u2013157 (2020). https:\/\/doi.org\/10.1016\/bs.ai.2019.11.005","journal-title":"Adv. Immunol. United States"},{"key":"1254_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2024.1346585","volume":"15","author":"H Wang","year":"2024","unstructured":"H. Wang, Y. Liu, S. Che, X. Li, D. Tang, S. Lv et al., Deciphering the link: ferroptosis and its role in glioma. Front. Immunol. 15, 1\u20132 (2024). https:\/\/doi.org\/10.3389\/fimmu.2024.1346585","journal-title":"Front. Immunol."},{"key":"1254_CR53","doi-asserted-by":"publisher","unstructured":"Y. Feng, Z. Yang, J. Wang, H. Zhao, Cuproptosis: unveiling a new frontier in cancer biology and therapeutics. 7, 1\u201326 (2024). https:\/\/doi.org\/10.1186\/s12964-024-01625-7","DOI":"10.1186\/s12964-024-01625-7"},{"key":"1254_CR54","doi-asserted-by":"publisher","first-page":"8131","DOI":"10.2147\/JIR.S526158","volume":"18","author":"P Li","year":"2025","unstructured":"P. Li, Y. Gao, Z. Tao, Z. Mu, S. Du, X. Zhao, PANoptosis, Cross-Talk Among Apoptosis, Necroptosis, and Pyroptosis in Neurological Disorders. J. Inflamm. Res. [Internet] Dove Med. Press. 18, 8131\u20138140 (2025). https:\/\/doi.org\/10.2147\/JIR.S526158","journal-title":"J. Inflamm. Res. [Internet] Dove Med. Press."},{"key":"1254_CR55","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1007\/s13402-025-01093-2","volume":"48","author":"G Jia","year":"2025","unstructured":"G. Jia, J. Li, M. Jiang, N. Liu, N. Ding, X. Jiang et al., Unraveling the miR-144-3p\/PUMA pathway: a novel regulator of FDX1-mediated cuproptosis in colorectal cancer. Cell. Oncol. [Internet]. 48, 1693\u20131710 (2025). https:\/\/doi.org\/10.1007\/s13402-025-01093-2","journal-title":"Cell. Oncol. [Internet]"},{"key":"1254_CR56","doi-asserted-by":"publisher","unstructured":"L. Alkharashi, I. Hasan, A. Almomen, Q.H. Alqahtani, Y.F. Mahran, A.M. Badr et al., HMGB1\/NF-\u03baB Axis, IL-8, and cuproptosis contribute to cisplatin-induced testicular injury: protective potential effect of thymol. Biomolecules. Switz. 15 (2025). https:\/\/doi.org\/10.3390\/biom15111595","DOI":"10.3390\/biom15111595"},{"key":"1254_CR57","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13578-024-01231-7","volume":"14","author":"Y Deng","year":"2024","unstructured":"Y. Deng, Q. Chen, C. Wan, Y. Sun, F. Huang, Y. Hu et al., Microglia and macrophage metabolism: a regulator of cerebral gliomas. Cell. Biosci. Springer. 14, 49 (2024)","journal-title":"Cell. Biosci. Springer"},{"key":"1254_CR58","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12943-025-02434-3","volume":"24","author":"F Du","year":"2025","unstructured":"F. Du, L. Tang, F. Wang, X. Jiang, J. Li, G. Wang et al., Epigenetic modification of cuproptosis by non-coding RNAs in cancer drug resistance. Mol. Cancer Springer. 24, 230 (2025)","journal-title":"Mol. Cancer Springer"},{"key":"1254_CR59","doi-asserted-by":"publisher","first-page":"e70146","DOI":"10.1002\/cbf.70146","volume":"43","author":"W Wang","year":"2025","unstructured":"W. Wang, L. Wang, X. Zhong, D. Li, L. Zhang, J. Hu, cGAS\u2013STING Signaling in Central Nervous System Diseases: Neuroinflammatory Mechanisms and Immune Regulation. Cell. Biochem. Funct. Wiley Online Libr. 43, e70146 (2025)","journal-title":"Cell. Biochem. Funct. Wiley Online Libr."},{"key":"1254_CR60","doi-asserted-by":"crossref","unstructured":"Z. Wu, G. Lian, L. He, P. Hu, Y. Guo, Z. Su, Targeting JAK\u2013STAT signaling for autoimmune diseases: current understanding, clinical advances, and emerging directions. Immunol. Cell. Biol. Wiley Online Libr. (2026)","DOI":"10.1111\/imcb.70078"},{"key":"1254_CR61","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s40478-025-02048-2","volume":"13","author":"BD Rowlands","year":"2025","unstructured":"B.D. Rowlands, B.G. Trist, C. Karozis, G. Schaffer, D. Mor, R. Harwood et al., Copper supplementation mitigates Parkinson-like wild-type SOD1 pathology and nigrostriatal degeneration in a novel mouse model. Acta Neuropathol. Commun. Springer. 13, 133 (2025)","journal-title":"Acta Neuropathol. Commun. Springer"},{"key":"1254_CR62","doi-asserted-by":"crossref","unstructured":"M.-H. Wen, H. Chen, G. Yan, Y. Zhang, W. Chen, M.V. Dokholyan et al., Elevated intracellular copper induces CTR1 monomerization and prevents copper uptake (Nat Commun. Nature Publishing Group UK London, 2025)","DOI":"10.1038\/s41467-025-66283-w"},{"key":"1254_CR63","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3390\/antiox14020142","volume":"14","author":"CR Oliva","year":"2025","unstructured":"C.R. Oliva, M.Y. Ali, S. Flor, C.E. Griguer, Copper-Induced Enhancement of Glioblastoma Tumorigenicity via Cytochrome C Oxidase. Antioxid. MDPI. 14, 142 (2025)","journal-title":"Antioxid. MDPI"},{"key":"1254_CR64","first-page":"22134","volume":"15","author":"J Zhang","year":"2025","unstructured":"J. Zhang, S.M. Lam, S. Ji, L. Zhang, J. Yin, H. Sun et al., Metabolic features of patients with repeated Omicron infections highlight new targets for therapeutic intervention. Sci. Rep. Nat. Publishing Group. 15, 22134 (2025)","journal-title":"Sci. Rep. Nat. Publishing Group."},{"key":"1254_CR65","doi-asserted-by":"publisher","first-page":"2404782","DOI":"10.1002\/adhm.202404782","volume":"14","author":"Y Guo","year":"2025","unstructured":"Y. Guo, L. Jin, Z. Shen, L. Fan, X. Yu, Y. Kuang et al., Biomimetic Membrane Vesicles Reprogram Microglia Polarization and Remodel the Immunosuppressive Microenvironment of Glioblastoma via PERK\/HIF-1\u03b1\/Glycolysis Pathway. Adv. Healthc. Mater. Wiley Online Libr. 14, 2404782 (2025)","journal-title":"Adv. Healthc. Mater. Wiley Online Libr."},{"key":"1254_CR66","first-page":"6581","volume":"86","author":"S Sebaoui","year":"2026","unstructured":"S. Sebaoui, Reprogramming microglial and GAMs phenotype and function, with HDAC inhibitors to overcome immune suppression in glioblastoma. Cancer Res. Am. Association Cancer Res. 86, 6581 (2026)","journal-title":"Cancer Res. Am. Association Cancer Res."},{"key":"1254_CR67","first-page":"1696","volume":"57","author":"B Viengkhou","year":"2024","unstructured":"B. Viengkhou, E. Hayashida, S. McGlasson, K. Emelianova, D. Forbes, S. Wiseman et al., The brain microvasculature is a primary mediator of interferon-\u03b1 neurotoxicity in human cerebral interferonopathies. Immun. Elsevier. 57, 1696\u20131709 (2024)","journal-title":"Immun. Elsevier"},{"key":"1254_CR68","doi-asserted-by":"crossref","unstructured":"A. Wu, K. Tu, G. Xia, The emerging role of ferredoxin 1 in cancer: Insights into cuproptosis and therapeutic innovation. Int. J. Biol. Macromol. 147996 (2025)","DOI":"10.1016\/j.ijbiomac.2025.147996"},{"key":"1254_CR69","doi-asserted-by":"publisher","first-page":"132","DOI":"10.2174\/0113892010301997240527162423","volume":"26","author":"Q Zhao","year":"2025","unstructured":"Q. Zhao, M. Yu, X. Du, Y. Li, J. Lv, X. Jiang et al., The role of cuproptosis key factor FDX1 in gastric cancer. Curr. Pharm. Biotechnol. Bentham Sci. Publishers. 26, 132\u2013142 (2025)","journal-title":"Curr. Pharm. Biotechnol. Bentham Sci. Publishers"},{"key":"1254_CR70","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1038\/s41467-026-68839-w","volume":"17","author":"H Negishi","year":"2026","unstructured":"H. Negishi, Y. Wada, Y. Shirasaki, T. Hayashi, Y. Kubota, T. Iwasaki et al., cGAS-IFN-I responses by extracting nuclear DNA from dying cells via nucleocytosis. Nat. Commun. [Internet]. 17, 1658 (2026). https:\/\/doi.org\/10.1038\/s41467-026-68839-w","journal-title":"Nat. Commun. [Internet]"},{"key":"1254_CR71","doi-asserted-by":"publisher","first-page":"8702","DOI":"10.1007\/s12035-024-04015-9","volume":"61","author":"A Mhaske","year":"2024","unstructured":"A. Mhaske, S. Shukla, K. Ahirwar, K.K. Singh, R. Shukla, Receptor-assisted nanotherapeutics for overcoming the blood\u2013brain barrier. Mol. Neurobiol. Springer. 61, 8702\u20138738 (2024)","journal-title":"Mol. Neurobiol. Springer"},{"key":"1254_CR72","first-page":"2894","volume":"8","author":"G Choe","year":"2002","unstructured":"G. Choe, J.K. Park, L. Jouben-Steele, T.J. Kremen, L.M. Liau, H.V. Vinters et al., Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype. Clin. Cancer Res. Am. Association Cancer Res. 8, 2894\u20132901 (2002)","journal-title":"Clin. Cancer Res. Am. Association Cancer Res."},{"key":"1254_CR73","first-page":"232","volume":"12","author":"M Cai","year":"2020","unstructured":"M. Cai, G. Chen, L. Qin, C. Qu, X. Dong, J. Ni et al., Metal organic frameworks as drug targeting delivery vehicles in the treatment of cancer. Pharm. MDPI. 12, 232 (2020)","journal-title":"Pharm. MDPI"},{"key":"1254_CR74","doi-asserted-by":"publisher","first-page":"eade8520","DOI":"10.1126\/science.ade8520","volume":"384","author":"J Zak","year":"2024","unstructured":"J. Zak, I. Pratumchai, B.S. Marro, K.L. Marquardt, R.B. Zavareh, L.L. Lairson et al., JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma. Sci. United States. 384, eade8520 (2024). https:\/\/doi.org\/10.1126\/science.ade8520","journal-title":"Sci. United States"},{"key":"1254_CR75","doi-asserted-by":"publisher","unstructured":"S.A. Sinyavskiy, N.S. Chmelyuk, D.Y. Travnikova, V.V. Belousov, T.O. Abakumova, Combination cancer therapy and reference models for assessing drug synergy in glioblastoma. Curr. Oncol. Switz. 33 (2025). https:\/\/doi.org\/10.3390\/curroncol33010019","DOI":"10.3390\/curroncol33010019"},{"key":"1254_CR76","doi-asserted-by":"publisher","unstructured":"F. Yuan, X. Wu, H. Yuan, D. Wang, T. Huang, P. Zhang et al., Glioblastoma stem cells resist cuproptosis with circadian variation of copper levels. J. Clin. Invest. 136 (2026). https:\/\/doi.org\/10.1172\/JCI192599","DOI":"10.1172\/JCI192599"},{"key":"1254_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2025.12.013","author":"L Li","year":"2026","unstructured":"L. Li, Q. Ye, J. Ma, Z. Wang, T. Liu, Y. Lei et al., Ubiquitination-directed cytosolic DNA degradation governs cGAS-STING-mediated immune response to DNA damage. Cancer Cell. United States. (2026). https:\/\/doi.org\/10.1016\/j.ccell.2025.12.013","journal-title":"Cancer Cell. United States"},{"key":"1254_CR78","doi-asserted-by":"publisher","first-page":"e70035","DOI":"10.1002\/wnan.70035","volume":"17","author":"J Zhou","year":"2025","unstructured":"J. Zhou, Y. Zhang, F. Dong, K. Matsuyama, Y. Tanaka, L. Wu, Mechanisms of Tumor Radiosensitization: A Perspective of Nano-Radiotherapy. Wiley Interdiscip Rev. Nanomed. Nanobiotechnol. United States. 17, e70035 (2025). https:\/\/doi.org\/10.1002\/wnan.70035","journal-title":"Wiley Interdiscip Rev. Nanomed. Nanobiotechnol. United States"},{"key":"1254_CR79","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1080\/15548627.2023.2200554","volume":"19","author":"Q Xue","year":"2023","unstructured":"Q. Xue, R. Kang, D.J. Klionsky, D. Tang, J. Liu, X. Chen, Copper metabolism in cell death and autophagy. Autophagy [Internet]. 19, 2175\u20132195 (2023). https:\/\/doi.org\/10.1080\/15548627.2023.2200554","journal-title":"Autophagy [Internet]"},{"key":"1254_CR80","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1289\/ehp.877559","volume":"75","author":"TW Clarkson","year":"1987","unstructured":"T.W. Clarkson, Metal toxicity in the central nervous system. Environ. Health Perspect. 75, 59 (1987)","journal-title":"Environ. Health Perspect."},{"key":"1254_CR81","first-page":"7126","volume":"19","author":"R Krishna Vadlapatla","year":"2013","unstructured":"R. Krishna Vadlapatla, A. Dutt Vadlapudi, D. Pal, A. K Mitra, Mechanisms of drug resistance in cancer chemotherapy: coordinated role and regulation of efflux transporters and metabolizing enzymes. Curr. Pharm. Des. Bentham Sci. Publishers. 19, 7126\u20137140 (2013)","journal-title":"Curr. Pharm. Des. Bentham Sci. Publishers"},{"key":"1254_CR82","doi-asserted-by":"crossref","unstructured":"S.H. Shahcheraghi, F. Salemi, W. Alam, H. Ashworth, L. Saso, H. Khan et al., The role of NRF2\/KEAP1 pathway in glioblastoma: pharmacological implications. Med. Oncol. 39, 91 (2022)","DOI":"10.1007\/s12032-022-01693-0"},{"key":"1254_CR83","first-page":"1490","volume":"14","author":"C D\u2019Antonio","year":"2025","unstructured":"C. D\u2019Antonio, G.L. Liguori, Modeling Glioblastoma for Translation: Strengths and Pitfalls of Preclinical Studies. Biology (Basel). MDPI. 14, 1490 (2025)","journal-title":"MDPI"},{"key":"1254_CR84","doi-asserted-by":"crossref","unstructured":"N. Samson, A. Ablasser, The cGAS\u2013STING pathway and cancer. Nat. cancer. 3, 1452\u20131463 (2022)","DOI":"10.1038\/s43018-022-00468-w"},{"key":"1254_CR85","first-page":"3149","volume":"81","author":"M Gr\u00f6nholm","year":"2021","unstructured":"M. Gr\u00f6nholm, M. Feodoroff, G. Antignani, B. Martins, F. Hamdan, V. Cerullo, Patient-derived organoids for precision cancer immunotherapy. Cancer Res. Am. Association Cancer Res. 81, 3149\u20133155 (2021)","journal-title":"Cancer Res. Am. Association Cancer Res."}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13402-026-01254-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-026-01254-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-026-01254-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:58:07Z","timestamp":1792061887000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13402-026-01254-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":85,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["1254"],"URL":"https:\/\/doi.org\/10.1007\/s13402-026-01254-x","relation":{},"ISSN":["2211-3436"],"issn-type":[{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"6 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Patient consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"138"}}